Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024

BUY
$209.01 - $232.56 $877,842 - $976,752
4,200 Added 107.69%
8,100 $1.77 Million
Q4 2023

Feb 14, 2024

BUY
$197.69 - $227.29 $59,307 - $68,187
300 Added 8.33%
3,900 $886,000
Q3 2023

Nov 14, 2023

BUY
$201.05 - $221.7 $643,360 - $709,440
3,200 Added 800.0%
3,600 $723,000
Q2 2023

Aug 14, 2023

BUY
$211.93 - $241.33 $84,772 - $96,532
400 New
400 $96,000
Q4 2019

Feb 14, 2020

SELL
$163.48 - $173.61 $1.45 Million - $1.55 Million
-8,900 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$159.77 - $178.1 $1.42 Million - $1.59 Million
8,900 New
8,900 $1.5 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.